Press release
Homozygous Familial Hypercholesterolemia (HoFH) Market Size, Analysis, Global Clinical Trials Review, H2, 2015: Acute Market Reports
GlobalData's clinical trial report, Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015" provides an overview of Homozygous Familial Hypercholesterolemia (HoFH) clinical trials scenario. This report provides top line data relating to the clinical trials on Homozygous Familial Hypercholesterolemia (HoFH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Browse full report with TOC @ acutemarketreports.com/report/homozygous-familial-hypercholesterolemia-hofh-global-clinical-trials-review-h2-2015
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
View all reports of this category @ acutemarketreports.com/category/pharmaceutical-market
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Blog URL: http://www.mobilecomputingtoday.co.uk/
About Acute Market Reports
Acute Market Reports is the most sufficient collection of market intelligence services online. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.
Contact:
Chris Paul
Office No 01, 1st Floor,
Aditi Mall, Baner, Pune,
MH, 411045 India
Phone (India): +91 7755981103
Toll Free (US/Canada): +1-855-455-8662
Email: sales@acutemarketreports.com
For More Information, Visit http://www.acutemarketreports.com/
Acute Market Reports is the most sufficient collection of market intelligence services online. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.
Office No 01, 1st Floor,
Aditi Mall, Baner, Pune,
MH, 411045 India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Homozygous Familial Hypercholesterolemia (HoFH) Market Size, Analysis, Global Clinical Trials Review, H2, 2015: Acute Market Reports here
News-ID: 325267 • Views: …
More Releases from Acute Market Reports
Pediatric Allergy Treatment Market Set to Soar: Projected to Reach $13.9 Billion …
The pediatric allergy treatment market is experiencing significant growth, driven by the rising prevalence of allergic conditions among children. Allergies, including food allergies, allergic rhinitis, asthma, and skin allergies, are becoming increasingly common in the pediatric population. This trend has led to a growing demand for effective treatment options that can provide relief and improve the quality of life for children affected by these conditions. The market for pediatric allergy…
Strippable Coatings Market Is Expected To Expand At A CAGR Of 7.1% From 2024 To …
Strippable coatings, also referred to as peelable coatings, are a type of non-flammable, water-based protective solution that can be easily removed from surfaces without the need for harsh chemical strippers or cleaners. Composed of water-based acrylic polymers, vapor phase corrosion inhibitors, and a thixotropic thickener, these coatings enhance barrier and surface protection properties. They can be applied via brush, spray, dip, or roll and are primarily utilized on bare metal…
Bakeware Market | Global Industry Size, Development Strategy, Revenue Analysis, …
The market for bakeware is a dynamic and evolving sector that serves both commercial and residential consumers. In 2023, the bakeware market was valued at $3,850.0 million and is projected to reach $6,462.2 million by the end of 2032. This market is anticipated to grow at a compound annual growth rate (CAGR) of 5.91% during the forecast period from 2024 to 2032. The growth is largely driven by a resurgence…
Global Wire Harness Market Set to Expand Through 2032 with Major Growth Drivers …
The global wire harness market is poised for robust growth, with a projected compound annual growth rate (CAGR) of 5.8% from 2024 to 2032. This growth trajectory is primarily driven by significant advancements in the automotive sector, escalating demand within consumer technology, and increasing applications in aerospace and defense sectors.
In the automotive industry, the wire harness market has seen substantial growth, primarily fueled by the advent of electric vehicles (EVs)…
More Releases for Homozygous
Homozygous Familial Hypercholesterolemia (HoFH) Market Massive Growth opportunit …
Introduction
Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic lipid disorder characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels from birth, often exceeding 500 mg/dL. Caused by mutations in both alleles of the LDLR, APOB, or PCSK9 genes, HoFH leads to early-onset atherosclerosis, cardiovascular disease, and premature mortality if untreated.
Historically, management relied on lipid-lowering agents, LDL apheresis, and lifestyle modifications. However, the last decade has witnessed a paradigm shift with…
Homozygous Familial Hypercholesterolemia Market 2025 | Market Growth, Genetic Sc …
Homozygous Familial Hypercholesterolemia Market reached US$ 83.7 million in 2022 and is expected to reach US$ 101.8 million by 2030 growing with a CAGR of 2.5% during the forecast period 2023-2030, according to DataM Intelligence research report, as per DataM intelligence research report.
Homozygous Familial Hypercholesterolemia Market: Recent Industry Developments
United States
✅ Regeneron announced the FDA extension of Evkeeza use to children aged 5-11 with HoFH, making it the first ANGPTL3 inhibitor…
New Syndrome: seemingly unrelated symptoms have a common cause in patients with …
The International H63D Mutation Research Consortium www.h63d-syndrome.org has announced the discovery of "Typ-2 H63D Syndrome", a genetic disease caused by a homozygous mutation of the HFE gene H63D. The research work, which spanned 12 years, uncovered that the mutation is responsible for a wide range of symptoms due to micro-inflammations, which can be challenging to diagnose without the proper knowledge and testing.
While classic Typ-1 H63D Syndrome is a rare disorder…
Latest Homozygous Familial Hypercholesterolemia Treatment Market Research | Comp …
Homozygous Familial Hypercholesterolemia Treatment Market
Market Strides has added a new report titled, “Global Homozygous Familial Hypercholesterolemia Treatment Market Professional Report 2027” to its vast repository of research reports. This is a comprehensive report focused on the current and future prospects of the Global Homozygous Familial Hypercholesterolemia Treatment Market. The report also mentions the impact of the coronavirus pandemic on the market. Furthermore, the study includes the steps the leading industry…
Homozygous Familial Hypercholesterolemia Treatment Market Size - Technological A …
Up Market Research (UMR) has published a latest market research report on Global Homozygous Familial Hypercholesterolemia Treatment Market. The global report is prepared in collaboration with the leading industry experts and dedicated research analyst team to provide an enterprise with in-depth market insights and help them to take crucial business decisions. This report covers current market trends, opportunities, challenges, and detailed competitive analysis of the industry players in the market.
The…
2017 Study - Homozygous Familial Hypercholesterolemia (HoFH) Market H1 Pipeline …
Latest niche market research study on "H1 Homozygous Familial Hypercholesterolemia (HoFH) Market Pipeline Review 2017 " Published at Orbisresearch.com
Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H1 2017, provides an overview of the Homozygous Familial
Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape.
Homozygous familial hypercholesterolemia is a genetic disorder which is caused due to mutation from both parents. HoFH causes LDL cholesterol level to be very high. Symptoms include xanthelasmas, chest pain and…
